BD Vascular Access and Hazardous Drug Safety On-Demand Webinars

Evidence-based webinars from healthcare experts to enhance knowledge and strengthen skills

Vascular access management webinars





Dr. Frank A Drews, PhD

An examination of human error in healthcare settings. What can we do to mitigate the risk?Human error in hospitals is the third leading cause of death in the United States according to a 2016 study.  Mistakes in medical care can be dangerous resulting in death or serious injury. Even the best clinicians can make errors, but what can be done to minimize them in patient care, especially when procedures are being completed by well-meaning but imperfect humans? This presentation will examine the common contributors to human error and while error is part of our cognitive makeup, research in healthcare settings will be reviewed that highlights steps that can be taken to mitigate or “engineer out” some of that risk.  Dr. Drews examines the surprising impact of common occurrences in your everyday work life like interruptions, multi-tasking and time pressure that may contribute to error. Watch now

Michele Biscossi, ACNP-BC, MS, RN, CNL, VA-BC

Problem or Solution? Clinical Evidence connecting Needle-Free Connectors to Lower Rates of CLABSI and Occlusions

This presentation will look at types of evidence and why "real world studies" reporting actual clinical outcomes are more applicable to clinical practice decisions than laboratory studies. Watch now

Marc Stranz, PharmD

Barb Nickel,

Diving Deep into
Non-cytotoxic Infusates


Choosing the appropriate vascular access device to meet the prescribed treatment and duration needs can be challenging. With literally hundreds of intravenous drugs, and no one published central list on known irritants, vesicants, and peripherally compatible infusates, making the right device decision is even more complex to navigate. Additionally, to utilize the GAVeCeLT DAV Expert APP and the MAGIC® APP one must have extensive foundational knowledge of non-cytotoxic infusates. What is an irritant or vesicant? What drugs fit into those categories? What do the guidelines provide for decision-making?  This presentation describes the findings of a research project by three well known clinicians that initiated a review of manufacturer instructions for use and Gaharts 2021 Intravenous Medications for Infusion Complications. As a result, the Infusate Consideration Companion (ICC) tool was developed to assist with device selection and will be introduced and be made available during this session.

Watch now

Elizabeth Morrell, DNP, RN, NEA-BC

Reducing risks and improving vascular access outcomes

This presentation will cover complications with SPC, areas to focus on when implementing a collaborative vascular access management team, change management and understanding the results of first-insertion success, dwell times and economic impact of short peripheral catheters.

Watch now

Amanda Lynch BSN, RN, VA-BC

Thomas Savage BSN, RN, CEN, CFRN

Implementing a Vascular Access Team (VAT) at a Rural Community Hospital

This presentation discusses how one hospital developed a vascular access team and conducted a study to demonstrate whether creating a VAT can led to better outcomes for patients through standardization of evidence-based practice, monitoring, and education, combined with an increased number of vascular access device options.

Watch now

Megan Stuff,
RT(R), RT (CT),

Contrast enhanced CT: a comprehensive approach

This presentation focuses on implementing evidence-based best practices for contrast-enhanced CT procedures that may assist busy radiology departments achieve better outcomes and greater clinical efficiencies.

Watch now

Michele Biscossi, ACNP-BC, MS, RN, CNL, VA-BC

Vascular Access Device Care and Management

An overview of the risks associated with VADs in clinical practice and review of how organizations need to evaluate VAD Care and Management against the INS Standards of best practice. A novel evidence-based data collection tool will be introduced which may help drive clinical decisions as they relate to VADS.

Watch now

Cheryl Campos, DNP, RN-BC, CEN, CPHQ

Part 1 of a 2-part series: Implementation of Guidewire Peripheral IV Technology to Improve Care for DVA Patients in an Acute Care Hospital

Implementation of a special program to train nurses from various departments to identify difficult venous access (DVA) patients and successfully insert guide-wire assisted PIVs throughout the hospital to this compromised patient population. Part 1 of a 2-part series.

Watch now

Cheryl Campos, DNP, RN-BC, CEN, CPHQ

Part 2 of a 2-part series: Implementing Guidewire Peripheral IV Technology Hospital Wide to Improve Patient Outcomes

A retrospective analysis following a special program for difficult venous access (DVA) patients. Clinically significant findings were identified including higher first-time attempt success rates, longer catheter dwell times, opportunities for cost savings and prevention of more invasive lines, when guide-wire assisted peripheral IV catheters were inserted by specialty trained nurses. Part 2 of a 2-part series.

Watch now

Jon Bell, MSN,

Vascular Access in the Midst of COVID-19

This presentation examines the impact of COVID-19 on vascular access policies and practices, and the opportunity that vascular access specialists have to emphasize evidence-based best practices in these challenging times.


Labib Haddad, MD

The Importance of Peripheral IV Catheter Selection in the Quality and Safety of Cross-Sectional Imaging

Using evidence-based data, Dr.Haddad will discuss how to choose a safe and reliable venous access and review multiple imaging protocols while providing ample examples of real clinical situations.

Watch now

Lynn Hadaway, MEd, RN, NPD-BC, CRNI

Mitigating the Risk of Extravasation with Power Injection

This presentation is based on a literature review and highlights a case study approach to discuss lawsuits involving contrast extravasation, including discussion on techniques for catheter assessment and new technology to reduce this serious complication.

Watch now

Nadine Nakazawa, RN, BSN, VA-BC

Central Line Complications

Whether on insertion or post insertion, central lines carry some degree of risk for the patient. These risks can cause mortality and morbidity such as air embolism, pneumothorax, hemothorax, arterial puncture, thrombosis, and infection. As clinicians, it’s important to understand such risks to minimize negative consequences. This presentation will review central line risks, patient assessment, guidelines, and clinical literature. It will also discuss specific factors to consider in device selection and central line placement that promote the best patient outcomes possible.

Watch now

Hazardous drug safety webinars


Patricia C. Kienle, M.P.A., BCSCP, FASHP


Silvia Valero García

Developing HD Contamination Monitoring Guidelines: Global PerspectivesSince the U.S. National Institute for Occupational Safety and Health (NIOSH) Alert on Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings was released in 2004, there has been increased focus worldwide on HD safety. This educational activity will present experiences from practitioners globally as they have worked to develop guidelines and best practice recommendations for HD surface contamination monitoring. The faculty will discuss the process undertaken to develop the guidelines as well as highlight the specific recommendations made. 

Patricia C. Kienle, M.P.A., BCSCP, FASHP


Safe to Touch: How Nursing and Pharmacy can Partner on HD Surface Contamination MonitoringIn 2020, the Safe to Touch Consensus Conference was convened to develop statements on HD surface contamination monitoring in healthcare settings. These consensus statements provide an opportunity for nursing and pharmacy to collaborate in development and implementation of to improve the safe handling and monitoring of HDs in the healthcare setting. This presentation will review the Safe to Touch Consensus Conference statements and provide a practical, multidisciplinary approach to implementation.Watch Now

Discover the BD Vascular Access Management program

BD Vascular Access Management is an integrated approach designed to identify and address gaps in the vascular access process that may result in improved clinical outcomes, better patient experiences, and process and economic efficiencies.

Learn More

BD-24411 (12/21)